US pharmaceutical giant Moderna on Monday reported a "robust neutralizing antibody response" to its Covid vaccine in children aged 6-11, and said that it will submit the trial data to global regulators soon.
from US News Headlines, Latest USA News, US news live on Times of India https://ift.tt/3maiZZV
0 Comments